This is obviously a very risky stock but Bio-AMD with partner Zenosense continues to make steady progress. I'm of the opinion that patience will pay off, but there have been terrible missteps with Sysmex and former CFO in the past. All behind us.
Tom and team trying to move MIDS and COAG forward.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.